Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection (A58168) - R2 - Effective March 24, 2022

This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).

Effective Date: March 24, 2022

Summary of Article Changes: Under Article Text revised the table to add the last row for QSant™ (NephroSant). This revision is retroactive effective for dates of service on or after 7/4/2021.

Visit the Molecular Diagnostic Services (MolDX) webpage to access the locally hosted MolDX Medicare Coverage Article from the “Covered Tests” or the “Excluded Tests” webpage.

To view the complete listing of locally hosted coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Medicare Coverage Articles webpage.

 

Last Updated Apr 20 , 2022